Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 CAD | +3.12% | +18.56% | +371.43% |
Sales 2024 * | - | Sales 2025 * | 583K 426K | Capitalization | 134M 97.71M |
---|---|---|---|---|---|
Net income 2024 * | -16M -11.69M | Net income 2025 * | -19M -13.88M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 229 x |
P/E ratio 2024 * |
-8.17
x | P/E ratio 2025 * |
-7.38
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.73% |
Latest transcript on Medicenna Therapeutics Corp.
1 day | +23.87% | ||
1 week | +10.98% | ||
Current month | +3.23% | ||
1 month | +21.52% | ||
3 months | +336.36% | ||
6 months | +433.33% | ||
Current year | +357.14% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.98 | +3.12% | 136 678 |
24-04-24 | 1.92 | +23.87% | 397,631 |
24-04-23 | 1.55 | +1.31% | 70,982 |
24-04-22 | 1.53 | -6.71% | 162,794 |
24-04-19 | 1.64 | -1.80% | 81,864 |
Delayed Quote Toronto S.E., April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+357.14% | 97.44M | |
+4.09% | 43.84B | |
+46.28% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- MDNA Stock